Engimata is looking for partners and sponsors. Engimata's state of the art patented technology for design of freeze-stable vaccines provides a platform that can be used for improvement of stability of current and future vaccines against accidental freezing. Please contact us today to find out more about our approach in improving the freeze-stability of your vaccine.